Global Coalition for Adaptive Research Announces Key Updates on GBM AGILE Phase 2-3 Adaptive Platform Trial for Patients With Glioblastoma

LOS ANGELES–(BUSINESS WIRE)–Global Coalition for Adaptive Research (GCAR) announces key updates on GBM AGILE phase 2-3 adaptive platform trial for patients with glioblastoma.